カテゴリー： Market Monitor Global, 世界, 医療/バイオ

オレンシア（アバタセプト）薬剤の世界市場見通し2023年-2029年

◆英語タイトル：Orencia (abatacept) Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5855）

◆商品コード：MMG23JU5855
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Orencia (abatacept) Drug Market 調査レポートは次の情報を含め、グローバルにおけるのオレンシア（アバタセプト）薬剤市場規模と予測を収録しています。・世界のオレンシア（アバタセプト）薬剤市場：売上、2018年-2023年、2024年-2029年
・世界のオレンシア（アバタセプト）薬剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のオレンシア（アバタセプト）薬剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プレフィルドシリンジ」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

オレンシア（アバタセプト）薬剤のグローバル主要企業は、Bristol-Myers Squibbなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、オレンシア（アバタセプト）薬剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のオレンシア（アバタセプト）薬剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のオレンシア（アバタセプト）薬剤市場：タイプ別市場シェア、2022年
・プレフィルドシリンジ、バイアル

世界のオレンシア（アバタセプト）薬剤市場：用途別、2018年-2023年、2024年-2029年
世界のオレンシア（アバタセプト）薬剤市場：用途別市場シェア、2022年
・関節リウマチ、乾癬性関節炎、その他

世界のオレンシア（アバタセプト）薬剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のオレンシア（アバタセプト）薬剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるオレンシア（アバタセプト）薬剤のグローバル売上、2018年-2023年
・主要企業におけるオレンシア（アバタセプト）薬剤のグローバル売上シェア、2022年
・主要企業におけるオレンシア（アバタセプト）薬剤のグローバル販売量、2018年-2023年
・主要企業におけるオレンシア（アバタセプト）薬剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bristol-Myers Squibb

*************************************************************

・調査・分析レポートの概要
オレンシア（アバタセプト）薬剤市場の定義
市場セグメント
世界のオレンシア（アバタセプト）薬剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のオレンシア（アバタセプト）薬剤市場規模
世界のオレンシア（アバタセプト）薬剤市場規模：2022年 VS 2029年
世界のオレンシア（アバタセプト）薬剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのオレンシア（アバタセプト）薬剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のオレンシア（アバタセプト）薬剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：プレフィルドシリンジ、バイアル
オレンシア（アバタセプト）薬剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：関節リウマチ、乾癬性関節炎、その他
オレンシア（アバタセプト）薬剤の用途別グローバル売上・予測

・地域別市場分析
地域別オレンシア（アバタセプト）薬剤市場規模 2022年と2029年
地域別オレンシア（アバタセプト）薬剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bristol-Myers Squibb
...

Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody.
This report aims to provide a comprehensive presentation of the global market for Orencia (abatacept) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orencia (abatacept) Drug. This report contains market size and forecasts of Orencia (abatacept) Drug in global, including the following market information:
Global Orencia (abatacept) Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Orencia (abatacept) Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Orencia (abatacept) Drug companies in 2022 (%)
The global Orencia (abatacept) Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Prefilled Syringe Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Orencia (abatacept) Drug include Bristol-Myers Squibb. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orencia (abatacept) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orencia (abatacept) Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Orencia (abatacept) Drug Market Segment Percentages, by Type, 2022 (%)
Prefilled Syringe
Vial
Global Orencia (abatacept) Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Orencia (abatacept) Drug Market Segment Percentages, by Application, 2022 (%)
Rheumatoid Arthritis
Psoriatic Arthritis
Other
Global Orencia (abatacept) Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Orencia (abatacept) Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orencia (abatacept) Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Orencia (abatacept) Drug revenues share in global market, 2022 (%)
Key companies Orencia (abatacept) Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Orencia (abatacept) Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orencia (abatacept) Drug, market overview.
Chapter 2: Global Orencia (abatacept) Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Orencia (abatacept) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orencia (abatacept) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Orencia (abatacept) Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Orencia (abatacept) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orencia (abatacept) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orencia (abatacept) Drug Overall Market Size
2.1 Global Orencia (abatacept) Drug Market Size: 2022 VS 2029
2.2 Global Orencia (abatacept) Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Orencia (abatacept) Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Orencia (abatacept) Drug Players in Global Market
3.2 Top Global Orencia (abatacept) Drug Companies Ranked by Revenue
3.3 Global Orencia (abatacept) Drug Revenue by Companies
3.4 Global Orencia (abatacept) Drug Sales by Companies
3.5 Global Orencia (abatacept) Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Orencia (abatacept) Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Orencia (abatacept) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Orencia (abatacept) Drug Players in Global Market
3.8.1 List of Global Tier 1 Orencia (abatacept) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Orencia (abatacept) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Orencia (abatacept) Drug Market Size Markets, 2022 & 2029
4.1.2 Prefilled Syringe
4.1.3 Vial
4.2 By Type – Global Orencia (abatacept) Drug Revenue & Forecasts
4.2.1 By Type – Global Orencia (abatacept) Drug Revenue, 2018-2023
4.2.2 By Type – Global Orencia (abatacept) Drug Revenue, 2024-2029
4.2.3 By Type – Global Orencia (abatacept) Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Orencia (abatacept) Drug Sales & Forecasts
4.3.1 By Type – Global Orencia (abatacept) Drug Sales, 2018-2023
4.3.2 By Type – Global Orencia (abatacept) Drug Sales, 2024-2029
4.3.3 By Type – Global Orencia (abatacept) Drug Sales Market Share, 2018-2029
4.4 By Type – Global Orencia (abatacept) Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Orencia (abatacept) Drug Market Size, 2022 & 2029
5.1.2 Rheumatoid Arthritis
5.1.3 Psoriatic Arthritis
5.1.4 Other
5.2 By Application – Global Orencia (abatacept) Drug Revenue & Forecasts
5.2.1 By Application – Global Orencia (abatacept) Drug Revenue, 2018-2023
5.2.2 By Application – Global Orencia (abatacept) Drug Revenue, 2024-2029
5.2.3 By Application – Global Orencia (abatacept) Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Orencia (abatacept) Drug Sales & Forecasts
5.3.1 By Application – Global Orencia (abatacept) Drug Sales, 2018-2023
5.3.2 By Application – Global Orencia (abatacept) Drug Sales, 2024-2029
5.3.3 By Application – Global Orencia (abatacept) Drug Sales Market Share, 2018-2029
5.4 By Application – Global Orencia (abatacept) Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Orencia (abatacept) Drug Market Size, 2022 & 2029
6.2 By Region – Global Orencia (abatacept) Drug Revenue & Forecasts
6.2.1 By Region – Global Orencia (abatacept) Drug Revenue, 2018-2023
6.2.2 By Region – Global Orencia (abatacept) Drug Revenue, 2024-2029
6.2.3 By Region – Global Orencia (abatacept) Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Orencia (abatacept) Drug Sales & Forecasts
6.3.1 By Region – Global Orencia (abatacept) Drug Sales, 2018-2023
6.3.2 By Region – Global Orencia (abatacept) Drug Sales, 2024-2029
6.3.3 By Region – Global Orencia (abatacept) Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Orencia (abatacept) Drug Revenue, 2018-2029
6.4.2 By Country – North America Orencia (abatacept) Drug Sales, 2018-2029
6.4.3 US Orencia (abatacept) Drug Market Size, 2018-2029
6.4.4 Canada Orencia (abatacept) Drug Market Size, 2018-2029
6.4.5 Mexico Orencia (abatacept) Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Orencia (abatacept) Drug Revenue, 2018-2029
6.5.2 By Country – Europe Orencia (abatacept) Drug Sales, 2018-2029
6.5.3 Germany Orencia (abatacept) Drug Market Size, 2018-2029
6.5.4 France Orencia (abatacept) Drug Market Size, 2018-2029
6.5.5 U.K. Orencia (abatacept) Drug Market Size, 2018-2029
6.5.6 Italy Orencia (abatacept) Drug Market Size, 2018-2029
6.5.7 Russia Orencia (abatacept) Drug Market Size, 2018-2029
6.5.8 Nordic Countries Orencia (abatacept) Drug Market Size, 2018-2029
6.5.9 Benelux Orencia (abatacept) Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Orencia (abatacept) Drug Revenue, 2018-2029
6.6.2 By Region – Asia Orencia (abatacept) Drug Sales, 2018-2029
6.6.3 China Orencia (abatacept) Drug Market Size, 2018-2029
6.6.4 Japan Orencia (abatacept) Drug Market Size, 2018-2029
6.6.5 South Korea Orencia (abatacept) Drug Market Size, 2018-2029
6.6.6 Southeast Asia Orencia (abatacept) Drug Market Size, 2018-2029
6.6.7 India Orencia (abatacept) Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Orencia (abatacept) Drug Revenue, 2018-2029
6.7.2 By Country – South America Orencia (abatacept) Drug Sales, 2018-2029
6.7.3 Brazil Orencia (abatacept) Drug Market Size, 2018-2029
6.7.4 Argentina Orencia (abatacept) Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Orencia (abatacept) Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Orencia (abatacept) Drug Sales, 2018-2029
6.8.3 Turkey Orencia (abatacept) Drug Market Size, 2018-2029
6.8.4 Israel Orencia (abatacept) Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Orencia (abatacept) Drug Market Size, 2018-2029
6.8.6 UAE Orencia (abatacept) Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Orencia (abatacept) Drug Major Product Offerings
7.1.4 Bristol-Myers Squibb Orencia (abatacept) Drug Sales and Revenue in Global (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
8 Global Orencia (abatacept) Drug Production Capacity, Analysis
8.1 Global Orencia (abatacept) Drug Production Capacity, 2018-2029
8.2 Orencia (abatacept) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Orencia (abatacept) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Orencia (abatacept) Drug Supply Chain Analysis
10.1 Orencia (abatacept) Drug Industry Value Chain
10.2 Orencia (abatacept) Drug Upstream Market
10.3 Orencia (abatacept) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Orencia (abatacept) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Orencia (abatacept) Drug in Global Market
Table 2. Top Orencia (abatacept) Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Orencia (abatacept) Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Orencia (abatacept) Drug Revenue Share by Companies, 2018-2023
Table 5. Global Orencia (abatacept) Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Orencia (abatacept) Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Orencia (abatacept) Drug Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Orencia (abatacept) Drug Product Type
Table 9. List of Global Tier 1 Orencia (abatacept) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orencia (abatacept) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Orencia (abatacept) Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Orencia (abatacept) Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Orencia (abatacept) Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Orencia (abatacept) Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Orencia (abatacept) Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Orencia (abatacept) Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Orencia (abatacept) Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Orencia (abatacept) Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Orencia (abatacept) Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Orencia (abatacept) Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Orencia (abatacept) Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Orencia (abatacept) Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Orencia (abatacept) Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Orencia (abatacept) Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Orencia (abatacept) Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Orencia (abatacept) Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Orencia (abatacept) Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Orencia (abatacept) Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Orencia (abatacept) Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Orencia (abatacept) Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Orencia (abatacept) Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Orencia (abatacept) Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Orencia (abatacept) Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Orencia (abatacept) Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Orencia (abatacept) Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Orencia (abatacept) Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Orencia (abatacept) Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Orencia (abatacept) Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Orencia (abatacept) Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Orencia (abatacept) Drug Sales, (K Units), 2024-2029
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Orencia (abatacept) Drug Product Offerings
Table 48. Bristol-Myers Squibb Orencia (abatacept) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. Orencia (abatacept) Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Orencia (abatacept) Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Orencia (abatacept) Drug Production by Region, 2018-2023 (K Units)
Table 53. Global Orencia (abatacept) Drug Production by Region, 2024-2029 (K Units)
Table 54. Orencia (abatacept) Drug Market Opportunities & Trends in Global Market
Table 55. Orencia (abatacept) Drug Market Drivers in Global Market
Table 56. Orencia (abatacept) Drug Market Restraints in Global Market
Table 57. Orencia (abatacept) Drug Raw Materials
Table 58. Orencia (abatacept) Drug Raw Materials Suppliers in Global Market
Table 59. Typical Orencia (abatacept) Drug Downstream
Table 60. Orencia (abatacept) Drug Downstream Clients in Global Market
Table 61. Orencia (abatacept) Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Orencia (abatacept) Drug Segment by Type in 2022
Figure 2. Orencia (abatacept) Drug Segment by Application in 2022
Figure 3. Global Orencia (abatacept) Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Orencia (abatacept) Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Orencia (abatacept) Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Orencia (abatacept) Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Orencia (abatacept) Drug Revenue in 2022
Figure 9. By Type - Global Orencia (abatacept) Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Orencia (abatacept) Drug Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Orencia (abatacept) Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Orencia (abatacept) Drug Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Orencia (abatacept) Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Orencia (abatacept) Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 23. US Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 28. Germany Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 37. China Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 44. Brazil Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Orencia (abatacept) Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Orencia (abatacept) Drug Sales Market Share, 2018-2029
Figure 48. Turkey Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Orencia (abatacept) Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Orencia (abatacept) Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Orencia (abatacept) Drug by Region, 2022 VS 2029
Figure 54. Orencia (abatacept) Drug Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ オレンシア（アバタセプト）薬剤の世界市場見通し2023年-2029年(Orencia (abatacept) Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

オレンシア（アバタセプト）薬剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp